{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [["MRI hyperintensity", "encephalopathy", "headache", "ozone", "vision loss"]], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "31310327", "DateCompleted": {"Year": "2020", "Month": "07", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "07", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "07", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1111/head.13597"], "Journal": {"ISSN": "1526-4610", "JournalIssue": {"Volume": "59", "Issue": "9", "PubDate": {"Year": "2019", "Month": "Oct"}}, "Title": "Headache", "ISOAbbreviation": "Headache"}, "ArticleTitle": "Headache, Visual Loss, and Encephalopathy Associated With Intravenous Ozone Administration.", "Pagination": {"StartPage": "1643", "EndPage": "1644", "MedlinePgn": "1643-1644"}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA."}], "Identifier": ["0000-0002-1709-2250"], "LastName": "Tong", "ForeName": "Olivia", "Initials": "O"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, Weill Cornell Medical College, New York, NY, USA."}], "Identifier": ["0000-0002-5426-5333"], "LastName": "Robbins", "ForeName": "Matthew S", "Initials": "MS"}], "PublicationTypeList": ["Case Reports", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Headache", "NlmUniqueID": "2985091R", "ISSNLinking": "0017-8748"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Oxidants"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Intravenous"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["etiology"], "DescriptorName": "Brain Diseases"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Headache"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Imaging"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Oxidants"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Vision Disorders"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646-682."}], "Title": "Reference"}], "History": [{"Year": "2019", "Month": "5", "Day": "15"}, {"Year": "2019", "Month": "7", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "17", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31310327", "10.1111/head.13597"]}}]}